MarketInOut Stock Screener Log In | Sign Up
 

Marinomed Biotech AG

VIE • Healthcare • Biotechnology • Quote as of 08/11/2026 13:30
Marinomed Biotech AG stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeVIE
Market Capitalization10.79 mln
Float1.37 mln
Earnings Date09/17/2025

EPS

9.76
Strong

P / E

0.48
Anomalous

Piotroski F-Score

5 / 9
Neutral

Beneish M-Score

11.86
Highly suspicious

Relative Strength

1 / 100
Severely lagging

Debt / Equity

-1.62
Negative equity

Business Description

Marinomed Biotech AG is an Austrian company founded in 2006 that researches and develops medicines for viral and immune-related conditions, selling its products across Europe and beyond. Its current portfolio includes treatments for allergic rhinitis, inflammatory eye diseases, and respiratory infections. The company also offers development and testing services for pharmaceutical formulations through its Solv4U platform, and works alongside SPH Sine Pharmaceutical Laboratories as a technology partner.

Key Fundamentals

EPS9.76
P/E0.48
RPS4.30
ROIC-1.26
ROA248
EBITDA, mln18.98
EV / EBITDA1.17
EV / EBIT1.19
Revenue, mln7.69
EV / Revenue2.89

Financial Strength

Altman Z-Score-1.32
Piotroski F-Score 5 / 9
Beneish M-Score11.86

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -12.96% 2 / 100   
1 Month -48.63% 0 / 100   
2 Months -65.69% 0 / 100   
6 Months -75.13% 0 / 100   
1 Year -75.26% 0 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us